Back to News
Market Impact: 0.2
Precision BioSciences, Inc. Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Source: Nasdaq
Healthcare & BiotechIPOs & SPACs
On November 5, 2026, Precision BioSciences entered into an underwriting agreement with TD Securities (USA) LLC and Guggenheim Securities, LLC, as representatives of the underwriters, for an offering of 10,235,077 shares. The article excerpt does not state the offering price or expected proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
More News
- OpenAI reportedly raises an additional $11 billion at a $1.25 trillion valuation
- Apollo-backed dental firm vVardis seeks up to $229 million in US IPO
- Anthropic IPO Investors Weigh Valuation as Low as $1.2 Trillion
- Anthropic IPO announcement odds drop on Kalshi following midterms and AI sell-off
- Jobs Boom Meets AI Market Turmoil
- Anthropic IPO valuation discussions fall to $1.3 trillion, Bloomberg reports